10 Fast-Growing Small Cap Stocks to Buy According to Analysts

​4. PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

Market Capitalization: $1.66 billion

Year-over-year Revenue Growth: 50.07%

3-Year Revenue Growth: 69.69%

Number of Hedge Fund Holders: 26

Analyst Upside Potential: 102.09%

​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On November 10, Matthew O’Brien from Piper Sandler reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) with a price target of $50. This follows the analyst’s earlier price target reduction from $55 to $50, and a Buy rating on November 4.

​The price target was reduced despite the company exceeding expectations in its fiscal Q3 2025 results announced on November 4. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) grew its revenue by 42.76% to $83.33 million, surpassing estimates by $2.56 million. Moreover, the EPS of negative $0.38 also topped the consensus by $0.04. Management attributed the revenue growth to strong demand for its HYDROS Robotic System, which grew 43% year-over-year, followed by a growing adoption of Aquablation therapy.

​Analyst Matthew O’Brien noted that the company’s Q3 performance was better than expected, and the 2025 and 2026 sales forecasts are also close to Wall Street’s expectations. However, he highlighted that the bears will focus on soft utilization performance and investor destocking. Regardless, the analyst believes these issues to be temporary, caused by some internal changes in the company. The firm anticipates these changes to reap positive results for the company.

​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) develops and sells the AQUABEAM Robotic System, which is a surgical robot that uses real-time imaging and a heat-free water jet to precisely remove prostate tissue.